Market Research Life Sciences Market Research Diagnostics Market Research In Vitro Diagnostics Market Research Immunoassays Market Research

Global Autoimmune Disease Diagnosis Market 

Best Price Guarantee Length Publisher Published Date SKU
from $5,150 455 Pages Fatpos Global March, 2024 FAGL18995246
Best Price Guarantee
Price from $5,150
Length 455 Pages
Publisher Fatpos Global
Published Date March, 2024
SKU FAGL18995246

Global Autoimmune Disease Diagnosis Market 


The Autoimmune Disease Diagnosis market was valued at USD 4801.6 million in 2022, and it is projected to reach USD 9296.1 million by 2030, at an estimated CAGR of 8.6% during the forecast period.

Advancements in Diagnostic Technologies:

There's a continuous evolution in diagnostic technologies, including next-generation sequencing (NGS), multiplex assays, and digital pathology, enabling more accurate, sensitive, and efficient detection of autoimmune diseases. Companies are investing in developing innovative platforms and assays that offer improved specificity and faster turnaround times.

Personalized Medicine:

There's a growing trend towards personalized medicine in autoimmune disease diagnostics, where treatments are tailored to individual patient characteristics, such as genetic makeup, biomarker profiles, and disease subtypes. Diagnostic companies are developing companion diagnostics and molecular tests to enable precision medicine approaches for autoimmune diseases.

Point-of-Care Testing (POCT):

Point-of-care testing for autoimmune diseases is gaining traction due to its convenience, rapid results, and potential for decentralized testing. Companies are developing POCT devices and assays for autoimmune biomarkers, allowing for early detection, monitoring, and management of autoimmune conditions in various settings, including clinics, pharmacies, and home care.

Digital Health Solutions:

There's a rising adoption of digital health solutions, such as telemedicine, remote monitoring, and mobile applications, in autoimmune disease diagnostics. Companies are integrating digital technologies into diagnostic platforms to enable remote consultations, patient monitoring, and data-driven insights for autoimmune disease management.

Expansion into Emerging Markets:

Diagnostic companies are expanding their presence in emerging markets with increasing healthcare expenditures and prevalence of autoimmune diseases. They're establishing partnerships, distribution networks, and local operations to address the growing demand for autoimmune disease diagnostics in regions such as Asia-Pacific, Latin America, and the Middle East.

Focus on Autoimmune Panels:

There's a shift towards offering comprehensive autoimmune panels and panels targeting specific autoimmune diseases, allowing for simultaneous testing of multiple biomarkers associated with different autoimmune conditions. Companies are developing multiplex assays and panels that offer comprehensive profiling and differential diagnosis of autoimmune diseases.


Chapter 1 Executive Summary
1.1 Business Trends
1.1.1 Advancements in Diagnostic Technologies:
1.1.2 Personalized Medicine:
1.1.3 Point-of-Care Testing (POCT):
1.1.4 Digital Health Solutions:
1.1.5 Expansion into Emerging Markets:
1.1.6 Focus on Autoimmune Panels:
1.1.7 Regulatory Landscape:
1.1.8 Integration of Artificial Intelligence (AI) and Data Analytics:
1.2 Autoimmune Disease Diagnosis Market: COVID-19 Outbreak
1.2.1 Shift in Healthcare Priorities:
1.2.2 Delayed Diagnosis and Treatment:
1.2.3 Telemedicine and Remote Monitoring:
1.2.4 Rise in Diagnostic Testing Demand:
1.2.5 Emphasis on Home-based Testing:
1.2.6 Digital Health Solutions:
1.2.7 Supply Chain Disruptions:
1.2.8 Regulatory Flexibility:
Chapter 2 Introduction
2.1 Market Research Methodology
2.1.1 Research Process
2.1.2 Primary Research
2.1.3 Secondary Research
2.1.4 Data Collection Technique
2.1.5 Data Sources
2.2 Market Estimation Methodology
2.2.1 Limitations of the Study
2.3 Product Picture of Autoimmune Disease Diagnosis
2.4 Global Autoimmune Disease Diagnosis Market: Classification
2.5 Years Considered for the Study
Chapter 3 Market Characteristics
3.1 Market Definition
Chapter 4 Global Autoimmune Disease Diagnosis Market Insights
4.1 Covid-19 impact on Global economy
4.2 Industry Value Chain
4.2.1 Research and Development (R&D):
4.2.2 Manufacturing:
4.2.3 Distribution and Supply Chain:
4.2.4 Clinical Laboratories:
4.2.5 Healthcare Providers:
4.2.6 Patient Care:
4.2.7 Regulatory Compliance and Quality Assurance:
4.2.8 Education and Training:
4.2.9 Research and Clinical Trials:
Chapter 5 Macroeconomic Indicators
5.1 Macro Economic Outlook
5.1.1 Selected Economies Real GDP Growth (% change)
Chapter 6 Recent Developments
6.1 Recent Developments
6.1.1 Biomarker Discovery:
6.1.2 Multiplex Assays:
6.1.3 Point-of-Care Testing (POCT):
6.1.4 Digital Diagnostics:
6.1.5 Personalized Medicine:
6.1.6 Remote Monitoring Solutions:
6.1.7 Integration of Data Analytics:
6.1.8 Regulatory Advances:
Chapter 7 Market Dynamics
7.1 Drivers
7.1.1 High incidence and prevalence of autoimmune diseases
7.1.2 Increasing awareness about autoimmune diseases
7.2 Restraints
7.2.1 High capital requirements autoimmune diseases diagnostics company
7.3 Opportunities
7.3.1 Use of biosensors for autoimmune disease diagnosis
7.3.2 Growth in the number of research activities on autoimmune diseases
7.4 Market Trends
7.4.1 Precision Medicine and Biomarker Discovery:
7.4.2 Multiplexed Assays and Point-of-Care Testing (POCT):
7.4.3 Digital Health and Remote Monitoring:
7.4.4 Artificial Intelligence and Machine Learning:
7.4.5 Microbiome and Environmental Factors:
7.4.6 Integration of Imaging Modalities:
Chapter 8 Risk Analysis
8.1 Demand & Supply Risk
8.1.1 Demand Risks:
8.1.2 Supply Risks:
8.2 Recent developments around Autoimmune Disease Diagnosis industry (2020 – till date)
Chapter 9 Market Analysis
9.1 Porter’s Analysis
9.1.1 Supplier Power
9.1.2 Buyer Power
9.1.3 Substitution Threat
9.1.4 Threat from New Entry
9.1.5 Competitive Rivalry
9.2 PESTEL Analysis
9.2.1 Political
9.2.2 Economic Factors:
9.2.3 Social Factors:
9.2.4 Technological Factors:
9.2.5 Environmental Factors:
9.2.6 Legal Factors:
Chapter 10 Global Autoimmune Disease Diagnosis Market
10.1 Global Autoimmune Disease Diagnosis
10.1.1 Global Autoimmune Disease Diagnosis Market Revenue (USD Million), 2016 – 2022
Chapter 11 Global Autoimmune Disease Diagnosis Market Analysis Forecast
11.1 Global Autoimmune Disease Diagnosis Market
11.1.1 Global Autoimmune Disease Diagnosis Market, by Region 2016 - 2030
11.1.2 Global Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.1.3 Global Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.1.4 Global Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.1.5 Global Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.2 North America Autoimmune Disease Diagnosis Market
11.2.1 North America Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.2.2 North America Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.2.3 North America Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.2.4 North America Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.3 United States
11.3.1 United States Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.3.2 United States Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.3.3 United States Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.3.4 United States Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.4 Canada
11.4.1 Canada Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.4.2 Canada Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.4.3 Canada Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.4.4 Canada Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.5 Europe
11.5.1 Europe Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.5.2 Europe Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.5.3 Europe Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.5.4 Europe Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.6 Germany
11.6.1 Germany Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.6.2 Germany Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.6.3 Germany Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.6.4 Germany Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.7 UK
11.7.1 UK Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.7.2 UK Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.7.3 UK Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.7.4 UK Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.8 France
11.8.1 France Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.8.2 France Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.8.3 France Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.8.4 France Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.9 Italy
11.9.1 Italy Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.9.2 Italy Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.9.3 Italy Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.9.4 Italy Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.10 Spain
11.10.1 Spain Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.10.2 Spain Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.10.3 Spain Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.10.4 Spain Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.11 Asia Pacific
11.11.1 Asia Pacific Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.11.2 Asia Pacific Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.11.3 Asia Pacific Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.11.4 Asia Pacific Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.12 China
11.12.1 China Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.12.2 China Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.12.3 China Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.12.4 China Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.13 Japan
11.13.1 Japan Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.13.2 Japan Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.13.3 Japan Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.13.4 Japan Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.14 South Korea
11.14.1 South Korea Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.14.2 South Korea Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.14.3 South Korea Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.14.4 South Korea Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.15 India
11.15.1 India Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.15.2 India Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.15.3 India Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.15.4 India Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.16 Latin America
11.16.1 Latin America Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.16.2 Latin America Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.16.3 Latin America Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.16.4 Latin America Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.17 Brazil
11.17.1 Brazil Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.17.2 Brazil Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.17.3 Brazil Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.17.4 Brazil Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.18 Argentina
11.18.1 Argentina Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.18.2 Argentina Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.18.3 Argentina Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.18.4 Argentina Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.19 Colombia
11.19.1 Colombia Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.19.2 Colombia Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.19.3 Colombia Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.19.4 Colombia Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.20 MEA
11.20.1 MEA Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.20.2 MEA Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.20.3 MEA Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.20.4 MEA Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.21 GCC
11.21.1 GCC Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.21.2 GCC Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.21.3 GCC Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.21.4 GCC Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.22 South Africa
11.22.1 South Africa Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.22.2 South Africa Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.22.3 South Africa Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.22.4 South Africa Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
11.23 Israel
11.23.1 Israel Autoimmune Disease Diagnosis Market, by type 2016 - 2030
11.23.2 Israel Autoimmune Disease Diagnosis Market, by Test type 2016 - 2030
11.23.3 Israel Autoimmune Disease Diagnosis Market, by disease 2016 - 2030
11.23.4 Israel Autoimmune Disease Diagnosis Market, by End-User2016 - 2030
Chapter 12 Competitive Landscape
12.1 Autoimmune Disease Diagnosis Market Share
Chapter 13 Competitive Analysis
13.1 Aesku Group GmbH & Co. KG
13.1.1 Business Overview
13.1.2 Aesku Group GmbH & Co. KG Business Financials (USD Million)
13.1.3 Aesku Group GmbH & Co. KG Product Category, Type and Specification
13.1.4 Aesku Group GmbH & Co. KG Main Business/Business Overview
13.1.5 Aesku Group GmbH & Co. KG Recent Development
13.1.6 Swot Analysis
13.2 ABBOTT
13.2.1 Business Overview
13.2.2 Abbott Business Financials (USD Million)
13.2.3 Abbott Product Category, Type and Specification
13.2.4 Abbott Main Business/Business Overview
13.2.5 Abbott Recent Development
13.2.6 Swot Analysis
13.3 THERMO FISHER SCIENTIFIC
13.3.1 Business Overview
13.3.2 Thermo Fisher Scientific Business Financials (USD Million)
13.3.3 Thermo Fisher Scientific Product Category, Type and Specification
13.3.4 Thermo Fisher Scientific Main Business/Business Overview
13.3.5 Thermo Fisher Scientific Recent Development
13.3.6 Swot Analysis
13.4 DANAHER
13.4.1 Business Overview
13.4.2 Danaher Business Financials (USD Million)
13.4.3 Danaher Product Category, Type and Specification
13.4.4 Danaher Main Business/Business Overview
13.4.5 Danaher Recent Development
13.4.6 Swot Analysis
13.5 HYCOR BIOMEDICAL
13.5.1 Business Overview
13.5.2 Hycor Biomedical Business Financials (USD Million)
13.5.3 Hycor Biomedical Product Category, Type and Specification
13.5.4 Hycor Biomedical Main Business/Business Overview
13.5.5 Swot Analysis
13.6 SIEMENS
13.6.1 Business Overview
13.6.2 Siemens Business Financials (USD Million)
13.6.3 Siemens Product Category, Type and Specification
13.6.4 Siemens Main Business/Business Overview
13.6.5 Siemens Recent Development
13.6.6 Swot Analysis
13.7 INOVA DIAGNOSTICS
13.7.1 Business Overview
13.7.2 Inova Diagnostics Business Financials (USD Million)
13.7.3 Inova Diagnostics Product Category, Type and Specification
13.7.4 Inova Diagnostics Main Business/Business Overview
13.7.5 Inova Diagnostics Recent Development
13.7.6 Swot Analysis
13.8 TRINITY BIOTECH
13.8.1 Business Overview
13.8.2 Trinity Biotech Business Financials (USD Million)
13.8.3 Trinity Biotech Product Category, Type and Specification
13.8.4 Trinity Biotech Main Business/Business Overview
13.8.5 Trinity Biotech Recent Development
13.8.6 Swot Analysis
13.9 BIO-RAD
13.9.1 Business Overview
13.9.2 Bio-Rad Business Financials (USD Million)
13.9.3 Bio-Rad Product Category, Type and Specification
13.9.4 Bio-Rad Main Business/Business Overview
13.9.5 Bio-Rad Recent Development
13.9.6 Swot Analysis
13.10 GRIFOLS
13.10.1 Business Overview
13.10.2 Grifols Business Financials (USD Million)
13.10.3 Grifols Product Category, Type and Specification
13.10.4 Grifols Main Business/Business Overview
13.10.5 Grifols Recent Development
13.10.6 Swot Analysis
Chapter 14 Recommendations
Disclaimer

$5,150
$8,550

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings